Evidence map›Paper›PMID 41757350›Full record

ArticleFrontiers in cellular neuroscience2026

C9orf72-ALS mutation drives basal mitophagy impairments in iNeurons.

James A K Lee, Chloe Moutin, Sarah Granger, Katie Roome, Allan Shaw, Scott P Allen, Laura Ferraiuolo, Pamela J Shaw, Heather Mortiboys

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

James A K LeeDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Chloe MoutinDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Sarah GrangerDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Katie RoomeDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Allan ShawDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Scott P AllenDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Laura FerraiuoloDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Pamela J ShawDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Heather MortiboysDivision of Neuroscience, School of Medicine and Population and Health, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: ALS is a neurodegenerative disorder characterized by progressive upper and lower motor neuron loss. A GGGGCC hexanucleotide repeat expansion (HRE) in the C9orf72 gene is the most common mutation found in populations of European descent. Mitochondrial dysfunction has been observed in C9orf72-ALS patients and models of the disease, however, reports on mitochondrial clearance via mitophagy in C9orf72-ALS are limited. Results: iNeurons from C9orf72-ALS patients displayed reduced mitochondrial membrane potential and reduced basal mitophagy, due to reductions in autophagosome production and reduced ULK1 recruitment to mitochondria. No consistent changes to PINK1/Parkin or BNIP3 mitophagy pathways were observed. Conclusion: Our data show that certain aspects of mitochondrial function is impaired in C9orf72-ALS patient iNeurons. An in-depth characterization of mitophagy suggests that a deficit in autophagosome production is responsible and provides further evidence that toxic gain-of-function mechanisms in C9orf72-ALS are responsible for autophagy deficits.

Indexed as

ALS (Amyotrophic lateral sclerosis)autophagymitochondriamitophagyULK1

Identifiers

PMID41757350
PMCPMC12933941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.